Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease.

Trial Profile

Safety and Efficacy of Melperone in the Treatment of Patients With Psychosis Associated With Parkinson's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Aug 2014

At a glance

  • Drugs Melperone (Primary)
  • Indications Parkinson's disease; Psychotic disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Actual patient number (90) added as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Additional trial centres identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top